Department of Radiology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine (SKKU-SOM), Changwon 51353, Republic of Korea.
Department of Anesthesia and Pain Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine (SKKU-SOM), Changwon 51353, Republic of Korea.
Eur J Radiol. 2023 Sep;166:110976. doi: 10.1016/j.ejrad.2023.110976. Epub 2023 Jul 13.
The incidence of tract seeding after the placement of indwelling pleural catheter (IPC) for malignant pleural effusion drainage has been variable in the literature.
To evaluate the incidence of IPC-related cancer tract seeding and find out related demographic, clinical or imaging factors to the tract seeding.
This retrospective study included 124 consecutive patients seen between January 2011 and December 2021 who underwent IPC placement for malignant pleural effusion drainage. Chest radiographs before IPC placement and serial chest CT studies were obtained. One patient was diagnosed pathologically, and the other patients were diagnosed as tract seeding radiologically. The incidence of and related factors to tract seeding were assessed by reviewing medical records and imaging studies.
The incidence of IPC tract seeding was 21.7% (27 of 124 malignant effusions). Of 27 patients, 15 had primary lung cancer and remaining 12 had extra-thoracic malignancy. Adenocarcinoma (19 of 27, 70.3%) either from the lung (N = 12) or extra-thoracic malignancy (N = 7) was the most common cell type. Mean time elapsed until tract seeding occurrence after IPC placement was 96 days (ranges; 28-306 days). The survival in seeding group after IPC placement was 185 days (ranges, 32-457 days). On odd ratio analysis, the presence of mediastinal pleural thickening (OR [95% CI]; 9.79 (2.67-35.84), p = 0.001) was significantly related to the occurrence of tract seeding. Neither tumor volume within pleural space (p = 0.168), duration of IPC indwelling (p = 0.142), days of survival after IPC placement (p = 0.26), nor pleural effusion amount (p = 0.481) was related to the tract seeding.
IPC tract seeding is seen in 27 (21.7%) of 124 malignant pleural effusion patients, particularly with adenocarcinoma cytology. CT features of mediastinal pleural thickening are related to the occurrence of tract seeding.
文献中留置胸腔导管(IPC)引流恶性胸腔积液后发生导管种植的发生率各不相同。
评估 IPC 相关癌症种植管的发生率,并找出与种植管相关的人口统计学、临床或影像学因素。
本回顾性研究纳入了 2011 年 1 月至 2021 年 12 月期间因恶性胸腔积液引流而行 IPC 放置的 124 例连续患者。在放置 IPC 之前获取胸部 X 线片和连续胸部 CT 研究。1 例患者经病理诊断,其余患者经影像学诊断为种植管。通过回顾病历和影像学研究评估种植管的发生率及相关因素。
IPC 种植管的发生率为 21.7%(124 例恶性胸腔积液中有 27 例)。27 例患者中,15 例为原发性肺癌,其余 12 例为胸外恶性肿瘤。腺癌(27 例中有 19 例,70.3%)来自肺部(N=12)或胸外恶性肿瘤(N=7)是最常见的细胞类型。IPC 放置后发生种植管的时间平均为 96 天(范围为 28-306 天)。IPC 放置后种植组的生存率为 185 天(范围为 32-457 天)。在比值比分析中,纵隔胸膜增厚的存在(比值比[95%CI];9.79(2.67-35.84),p=0.001)与种植管的发生显著相关。胸腔内肿瘤体积(p=0.168)、IPC 留置时间(p=0.142)、IPC 放置后生存天数(p=0.26)和胸腔积液量(p=0.481)均与种植管无关。
124 例恶性胸腔积液患者中有 27 例(21.7%)发生 IPC 种植管,特别是腺癌细胞学。纵隔胸膜增厚的 CT 特征与种植管的发生有关。